FTC’s Test Case Opposing Amgen-Horizon Deal Ends With No-Bundling Agreement

 
• By Brenda Sandburg
merger horizon
Federal Trade Commission reaches consent order allowing Amgen's acquisition of Horizon Therapeutics • Source: Shutterstock

More from Legal & IP

More from Pink Sheet